New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation.

S, Chatterjee; P, Sardar; G, Biondi-Zoccai; DJ, Kumbhani

doi:10.1001/jamaneurol.2013.4021

Public

New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation.

Shared by NobleBlocks on Dec 1, 2013 • 12:00 AM UTC

Authors:

Chatterjee S

Sardar P

Biondi-Zoccai G

Abstract

Importance Randomized studies have shown a decreased risk of intracranial hemorrhage (ICH) with use of novel oral anticoagulants (NOACs). However, it is unclear whether the magnitude of benefit is similar for all NOACs currently available.Objective To perform a systematic review and meta-analysis to...

Discussions